Investigation on the Prevalence of Canine Microfilaremia in Thailand Using a Novel Microfluidic Device in Combination with Real
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
The Functional Parasitic Worm Secretome: Mapping the Place of Onchocerca Volvulus Excretory Secretory Products
pathogens Review The Functional Parasitic Worm Secretome: Mapping the Place of Onchocerca volvulus Excretory Secretory Products Luc Vanhamme 1,*, Jacob Souopgui 1 , Stephen Ghogomu 2 and Ferdinand Ngale Njume 1,2 1 Department of Molecular Biology, Institute of Biology and Molecular Medicine, IBMM, Université Libre de Bruxelles, Rue des Professeurs Jeener et Brachet 12, 6041 Gosselies, Belgium; [email protected] (J.S.); [email protected] (F.N.N.) 2 Molecular and Cell Biology Laboratory, Biotechnology Unit, University of Buea, Buea P.O Box 63, Cameroon; [email protected] * Correspondence: [email protected] Received: 28 October 2020; Accepted: 18 November 2020; Published: 23 November 2020 Abstract: Nematodes constitute a very successful phylum, especially in terms of parasitism. Inside their mammalian hosts, parasitic nematodes mainly dwell in the digestive tract (geohelminths) or in the vascular system (filariae). One of their main characteristics is their long sojourn inside the body where they are accessible to the immune system. Several strategies are used by parasites in order to counteract the immune attacks. One of them is the expression of molecules interfering with the function of the immune system. Excretory-secretory products (ESPs) pertain to this category. This is, however, not their only biological function, as they seem also involved in other mechanisms such as pathogenicity or parasitic cycle (molting, for example). Wewill mainly focus on filariae ESPs with an emphasis on data available regarding Onchocerca volvulus, but we will also refer to a few relevant/illustrative examples related to other worm categories when necessary (geohelminth nematodes, trematodes or cestodes). -
American Journal of Veterinary Research
American Journal of Veterinary Research Index for Volume 71 No. 1 – 12 January – December 2010 Published by AMERICAN VETERINARY MEDICAL ASSOCIATION 1931 N MEACHAM RD, SUITE 100, SCHAUMBURG, IL 60173-4360 Index to News A American Anti-Vivisection Society (AAVS) AAHA Nutritional Assessment Guidelines for Dogs and Cats MSU veterinary college ends nonsurvival surgeries, 497 Nutritional assessment guidelines, consortium introduced, 1262 American Association of Swine Veterinarians (AASV) Abandonment AVMA board, HOD convene during leadership conference, 260 Corwin promotes conservation with pageant of ‘amazing creatures,’ 1115 AVMA seeks input on model practice act, 1403 American Association of Veterinary Immunologists (AAVI) CRWAD recognizes research, researchers, 258 Abbreviations FDA targets medication errors resulting from unclear abbreviations, 857 American Association of Veterinary Laboratory Diagnosticians (AAVLD) Abuse Organizations to promote veterinary research careers, 708 AVMA seeks input on model practice act, 1403 American Association of Veterinary Parasitologists (AAVP) Academy of Veterinary Surgical Technicians (AVST) CRWAD recognizes research, researchers, 258 NAVTA announces new surgical technician specialty, 391 American Association of Veterinary State Boards (AAVSB) Accreditation Stakeholders weigh in on competencies needed by veterinary grads, 388 Dates announced for NAVMEC, 131 USDA to restructure accreditation program, require renewal, 131 American Association of Zoo Veterinarians (AAZV) Education council schedules site -
Dirofilaria Immitis in Cats: Diagnosis and Management*
CE Article #2 Dirofilaria immitis in Cats: Diagnosis and Management * C. Thomas Nelson, DVM a Animal Medical Centers of Northeast Alabama Anniston, Alabama ABSTRACT: Imaging and laboratory studies can help with the diagnosis of heartworm disease in cats, but no test is definitive. Furthermore, even when the diagnosis can be reliably established, therapy directed at the heartworms does little to help the cat. Rather, management is directed at alleviating clinical signs, with an emphasis on prevention for all. iagnosis is the most challenging part of tions are often single sex. When microfilariae feline heartworm disease because are produced, they are only present for 1 or 2 Dno single test can reliably detect heart - months, at which time the cat’s immune sys - worms at all stages. Veterinarians must be will- tem eliminates them and suppresses further ing to conduct multiple and even repeat tests embryogenesis. 1 (Table 1 and Figure 1 ) to obtain a diagnosis and to correctly interpret and apply the results .b Radiology The most common radiographic finding in DIAGNOSIS feline heartworm disease is an enlargement of Microfilariae the right caudal lobar artery (see Figure 2 in the Filtration tests for microfilariae are virtually companion article beginning on page 382 ). This useless in cats because cats are only transiently is best seen on a ventrodorsal view. A bron - microfilaremic, if at all. To be microfilaremic, a chointerstitial pulmonary pattern (Figure 2) cat must have both a mature male and a may also be noted, but this finding is not mature female worm, and because cats typi - unique to feline heartworm disease. -
Dolo Et Al., 2020
Serological Evaluation of Onchocerciasis and Lymphatic Filariasis Elimination in the Bakoye and Falémé foci, Mali Housseini Dolo1,6*, Yaya I. Coulibaly1,2, Moussa Sow3, Massitan Dembélé4, Salif S. Downloaded from https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciaa318/5811165 by guest on 29 April 2020 Doumbia1, Siaka Y. Coulibaly1, Moussa B. Sangare1, Ilo Dicko1, Abdallah A. Diallo1, Lamine Soumaoro1, Michel E. Coulibaly1, Dansine Diarra5, Robert Colebunders6, Thomas B. Nutman7, Martin Walker8*, Maria-Gloria Basáñez9* 1 Lymphatic Filariasis Research Unit, International Center of Excellence in Research, Faculty of Medicine and Odontostomatology, Point G, Bamako, Mali 2 Centre National d’Appui à la lutte contre la Maladie (CNAM), Bamako, Mali 3 Programme National de Lutte contre l’Onchocercose, Bamako, Mali 4 Programme National d’Elimination de la Filariose Lymphatique, Bamako, Mali 5 Faculty of Geography and History, Bamako, Mali 6 Global Health Institute, University of Antwerp, Antwerp, Belgium 7 Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA 8 Department of Pathobiology and Population Sciences and London Centre for Neglected Tropical Disease Research, Royal Veterinary College, Hatfield, UK 9 Department of Infectious Disease Epidemiology and London Centre for Neglected Tropical Disease Research, MRC Centre for Global Infectious Disease Analysis, Imperial College London, UK * contributed equally to this work. Correspondence -
CDC Center for Global Health 2016 Annual Report
CDC CENTER FOR GLOBAL HEALTH (CGH) 2016 ANNUAL REPORT Photo Credit: Athit Perawongmtha Photo Credit: Ashley Greiner 2016 CENTER FOR GLOBAL HEALTH (CGH) ANNUAL REPORT Message from the Director CDC’s global health work has a clear mission: to protect and improve health globally through science, policy, partnership, and evidence- based public health action. By ensuring that countries have the capabilities to prevent, detect, and respond to or treat health threats within their borders, the Center for Global Health (CGH) helps prevent regional and global health crises that affect health, security, and economic stability abroad and at home. Rebecca Martin In 2016, CGH’s dedicated staff advanced this mission across many Director, Center for Global Health, disease goals and geographic areas around the world. This annual Centers for Disease Control report illustrates the work that has been done in 2016 and provides and Prevention a portrait of CGH’s priorities and achievements, and the work that remains. This report also illustrates why CDC’s global health work is important and how it contributes to protecting people’s health and quality of life, both in the United States and abroad. I am proud of the strategic and impactful work in CGH over the last year, often under difficult and challenging conditions. This report highlights how scientists, epidemiologists, laboratory specialists, and countless other highly-trained experts from CGH were instrumental in achieving immunization of children at risk, in pressing forward in the fight against HIV and tuberculosis (TB), and in leading the efforts to control malaria, Zika, and a collection of other dangerous diseases that still afflict far too many people. -
How Should Indonesia Consider Its Neglected Tropical Diseases in the COVID-19 Era? Hopes and Challenges (Review)
BIOMEDICAL REPORTS 14: 53, 2021 How should Indonesia consider its neglected tropical diseases in the COVID-19 era? Hopes and challenges (Review) SHIFA FAUZIYAH1, SERIUS MILIYANI DWI PUTRI1, ZUKHAILA SALMA1, HAMIDAH RETNO WARDHANI1, FARADILA KHOIRUN NISA' HAKIM1, TEGUH HARI SUCIPTO2, FEBRIANA AQUARESTA3,4 and SOEGENG SOEGIJANTO2,5 1Master Program of Tropical Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java 60132; 2Dengue Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, East Java 60115; 3Clinical Microbiology Specialist Program, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java 60132; 4Palembang Health Laboratory Center, Palembang, South Sumatra 30126; 5Department of Pediatric, Faculty of Medicine, Universitas Wijaya Kusuma Surabaya, Surabaya, East Java 60225, Indonesia Received December 3, 2020; Accepted March 24, 2021 DOI: 10.3892/br.2021.1429 Abstract. During the coronavirus disease 2019 (COVID‑19) Government‑supported integrated management is also a key pandemic, some countries, including Indonesia, have faced a component in eliminating NTD. Moreover, healthy lifestyle double burden with regards to disease control. As Indonesia campaigns that include social distancing, wearing a mask and is a tropical country, it serves as a suitable host for disease regularly washing hands should be promoted continuously to vectors and multiple microorganisms of causative agents of reduce the transmission of COVID‑19, which is potentially disease. In total, five of the neglected tropical diseases (NTDs) associated with a poor outcome in individuals with NTDs. should be a consideration in Indonesia during the COVID‑19 This review concluded that the Indonesian government should pandemic, including leprosy, yaws, filariasis, soil‑trans‑ strengthen their efforts toward NTD control using alternative mitted helminths and schistosomiasis. -
A Code of Practice for Canadian Kennel Operations Third Edition | 2018 a CODE of PRACTICE for CANADIAN KENNEL OPERATIONS
A Code of Practice for Canadian Kennel Operations Third edition | 2018 A CODE OF PRACTICE FOR CANADIAN KENNEL OPERATIONS Acknowledgements The third edition of this Code took seven years to complete. The Canadian Veterinary Medical Association (CVMA) expresses sincere appreciation to Amy Morris of the BC SPCA for her research, coordination, and drafting support, Dr. Sherlyn Spooner and Dr. Colleen Marion for their signifcant contributions to the Code’s development, and Dr. Warren Skippon and Dr. Shane Renwick for their leadership. The CVMA also wishes to express gratitude to the small animal subcommittee members who provided drafting, feedback, and guidance over the seven-year period: Dr. Patricia Turner, Dr. Carol Morgan, Dr. Alice Crook, Dr. Tim Zaharchuk, Dr. Jim Berry, Dr. Michelle Lem, Ms. Barb Cartwright, Dr. Michelle Groleau, Dr. Tim Arthur, Ms. Christine Archer, Dr. Chris Bell, Dr. Doug Whiteside, Dr. Michael Cockram, Dr. Patricia Alderson, Dr. Trevor Lawson, Dr. Gilly Griffn, and Dr. Marilyn Keaney. The CVMA thanks the following organizations and their representatives who were consulted to review the Code and provide comments before publication: provincial veterinary associations and regulatory licensing bodies, Canadian veterinary colleges, the American Veterinary Medical Association, the Canadian Federation of Humane Societies, Agriculture and Agri-Food Canada, the Canadian Kennel Club, the Pet Industry Joint Advisory Council of Canada, the National Companion Animal Coalition, and the Registered Veterinary Technologists and Technicians of Canada. © 2018 Canadian Veterinary Medical Association. This document or any portion thereof may be quoted or reproduced with proper attribution to the author ‘Canadian Veterinary Medical Association’. Canadian Veterinary Medical Association Third Edition | 2018 i A CODE OF PRACTICE FOR CANADIAN KENNEL OPERATIONS Preface Since the release of the Code of Practice for Canadian Kennel Operations second edition in 2007, both our society and science have advanced with respect to the humane treatment of dogs. -
Eisai Announces Results and Continued Support Of
No.17-18 April 19, 2017 Eisai Co., Ltd. EISAI ANNOUNCES RESULTS AND CONTINUED SUPPORT OF INITIATIVES FOR ELIMINATION OF LYMPHATIC FILARIASIS 5 YEAR ANNIVERSARY OF LONDON DECLARATION ON NEGLECTED TROPICAL DISEASES Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) has announced the results of its initiatives for the elimination of lymphatic filariasis (LF), and its continued support of this cause in the future. This announcement was made at an event held in Geneva, Switzerland, on April 18, marking the 5th anniversary of the London Declaration on Neglected Tropical Diseases (NTDs), an international public-private partnership. Announced in January 2012, the London Declaration is the largest public-private partnership in the field of global health, and represents a coordinated effort by global pharmaceutical companies, the Bill & Melinda Gates Foundation, the World Health Organization (WHO), the United States, United Kingdom and NTD-endemic country governments, as well as other partners, to eliminate 10 NTDs by the year 2020. Since the signing of the London Declaration, donations of medical treatments by pharmaceutical companies have increased by 70 percent, and these treatments contribute to the prevention and cure of disease in approximately 1 billion people every year. Under the London Declaration, Eisai signed an agreement with WHO to supply 2.2 billion high-quality diethylcarbamazine (DEC) tablets, which were running in short supply worldwide, at Price Zero (free of charge) by the year 2020. These DEC tablets are manufactured at Eisai’s Vizag Plant in India. As of the end of March 2017, 1 billion tablets have been supplied to 27 endemic countries. -
Companion Animals and Tick-Borne Diseases a Systematic Review
Companion animals and tick-borne diseases A systematic review Systematic Review December 2017 Public Health Ontario Public Health Ontario is a Crown corporation dedicated to protecting and promoting the health of all Ontarians and reducing inequities in health. Public Health Ontario links public health practitioners, frontline health workers and researchers to the best scientific intelligence and knowledge from around the world. Public Health Ontario provides expert scientific and technical support to government, local public health units and health care providers relating to the following: • communicable and infectious diseases • infection prevention and control • environmental and occupational health • emergency preparedness • health promotion, chronic disease and injury prevention • public health laboratory services Public Health Ontario's work also includes surveillance, epidemiology, research, professional development and knowledge services. For more information, visit publichealthontario.ca. How to cite this document: Ontario Agency for Health Protection and Promotion (Public Health Ontario). Companion animals and tick-borne diseases: a systematic review. Toronto, ON: Queen's Printer for Ontario; 2017. ISBN 978-1-4868-1063-5 [PDF] ©Queen’s Printer for Ontario, 2017 Public Health Ontario acknowledges the financial support of the Ontario Government. Companion animals and tick-borne diseases: a systematic review i Authors Mark P. Nelder, PhD Senior Program Specialist Enteric, Zoonotic & Vector-borne Diseases Communicable Diseases, Emergency -
Brugia Pahangi
RESEARCH ARTICLE Efficacy of subcutaneous doses and a new oral amorphous solid dispersion formulation of flubendazole on male jirds (Meriones unguiculatus) infected with the filarial nematode Brugia pahangi Chelsea Fischer1, Iosune Ibiricu Urriza1, Christina A. Bulman1, KC Lim1, Jiri Gut1, a1111111111 Sophie Lachau-Durand2, Marc Engelen2, Ludo Quirynen2, Fetene Tekle2, Benny Baeten2, 3 4 1 a1111111111 Brenda Beerntsen , Sara Lustigman , Judy SakanariID * a1111111111 a1111111111 1 Dept. of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, United States of America, 2 Janssen R&D, Janssen Pharmaceutica, Beerse, Belgium, 3 Veterinary a1111111111 Pathobiology, University of Missouri-Columbia, Columbia, Missouri, United States of America, 4 Laboratory of Molecular Parasitology, Lindsley F. Kimball Research Institute, New York Blood Center, New York, New York, United States of America * [email protected] OPEN ACCESS Citation: Fischer C, Ibiricu Urriza I, Bulman CA, Lim K, Gut J, Lachau-Durand S, et al. (2019) Efficacy of Abstract subcutaneous doses and a new oral amorphous solid dispersion formulation of flubendazole on River blindness and lymphatic filariasis are two filarial diseases that globally affect millions male jirds (Meriones unguiculatus) infected with of people mostly in impoverished countries. Current mass drug administration programs rely the filarial nematode Brugia pahangi. PLoS Negl on drugs that primarily target the microfilariae, which are released from adult female worms. Trop Dis 13(1): e0006787. https://doi.org/10.1371/ journal.pntd.0006787 The female worms can live for several years, releasing millions of microfilariae throughout the course of infection. Thus, to stop transmission of infection and shorten the time to elimi- Editor: Roger K. -
"Structure, Function and Evolution of the Nematode Genome"
Structure, Function and Advanced article Evolution of The Article Contents . Introduction Nematode Genome . Main Text Online posting date: 15th February 2013 Christian Ro¨delsperger, Max Planck Institute for Developmental Biology, Tuebingen, Germany Adrian Streit, Max Planck Institute for Developmental Biology, Tuebingen, Germany Ralf J Sommer, Max Planck Institute for Developmental Biology, Tuebingen, Germany In the past few years, an increasing number of draft gen- numerous variations. In some instances, multiple alter- ome sequences of multiple free-living and parasitic native forms for particular developmental stages exist, nematodes have been published. Although nematode most notably dauer juveniles, an alternative third juvenile genomes vary in size within an order of magnitude, com- stage capable of surviving long periods of starvation and other adverse conditions. Some or all stages can be para- pared with mammalian genomes, they are all very small. sitic (Anderson, 2000; Community; Eckert et al., 2005; Nevertheless, nematodes possess only marginally fewer Riddle et al., 1997). The minimal generation times and the genes than mammals do. Nematode genomes are very life expectancies vary greatly among nematodes and range compact and therefore form a highly attractive system for from a few days to several years. comparative studies of genome structure and evolution. Among the nematodes, numerous parasites of plants and Strikingly, approximately one-third of the genes in every animals, including man are of great medical and economic sequenced nematode genome has no recognisable importance (Lee, 2002). From phylogenetic analyses, it can homologues outside their genus. One observes high rates be concluded that parasitic life styles evolved at least seven of gene losses and gains, among them numerous examples times independently within the nematodes (four times with of gene acquisition by horizontal gene transfer. -
Historical Dermatology & Vaccines
9/24/2019 Historical Dermatology & Vaccines GREG SIMPSON MD Disclosures I do not have any relevant financial endorsements to disclose. I will be talking about the off label use of many medications UCSF Fresno Mini Med School 2019 1 9/24/2019 Outline History of select Infectious disease Infectious Disease and Vaccines Why the caduceus? UCSF Fresno Mini Med School 2019 2 9/24/2019 Case 1- 42 y.o. African male Dracunculiasis Guinea Worm Cyclops water flea in drinking water (carry the larvae) 1980’s- 3.5 million cases, 2018- 28 As of February 2019, only 7 countries remaining to be certified Guinea worm free: Angola, Chad, Democratic Republic of the Congo, Ethiopia, Mali, South Sudan, and Sudan Metronidazole or thiabendazole and stick Clean water sources, Larvicide (ABATE) or filters UCSF Fresno Mini Med School 2019 3 9/24/2019 CDC eradication program ERADICATED 1. Small Pox 2. Rinderpest GLOBAL ERADICATION UNDERWAY 1. Polio 2. Dracunculiasis 3. Yaws 4. Malaria REGIONAL ELIMINATION ESTABLISHED OR UNDERWAY 1. Hookworm 2. Lymphatic filariasis 3. Measles 4. Rubella 5. Onchocerciasis 6. Bovine spongiform encephalopathy (CJD) 7. Syphilis 8. Rabies Medical Significance? Asklepios- Greek God of medicine (1200 BC) Hippocrates 20th generation “follower” Today’s medical significance? Caduceus- Hermes (Greek) staff 1902- US Army and pharmacies used it as a “stamp” on medical supplies UCSF Fresno Mini Med School 2019 4 9/24/2019 The Black Death is estimated to have killed 30% to 60% of Europe’s population. In total, the plague may have reduced the world population from an estimated 450 million to 350–375 million in the 14th century.